+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sickle cell disease in Madhya Pradesh, Central India: A comparison of clinical profile of sickle cell homozygote vs. sickle-beta thalassaemia individuals

Sickle cell disease in Madhya Pradesh, Central India: A comparison of clinical profile of sickle cell homozygote vs. sickle-beta thalassaemia individuals

Hematology 21(9): 558-563

The clinical manifestation in sickle cell disease (SCD) patients varies from one individual to another due to factors like the presence of alpha-thalassaemia mutation, foetal haemoglobin, and β-globin gene haplotype. The present study enumerates the clinical profile of sickle cell anaemia patients from Central India. Seven hundred seventy-six SCD patients from Jabalpur and surrounding districts (Madhya Pradesh) in central India were registered with the sickle cell clinic of NIRTH, Jabalpur. The present study reveals recorded signs and symptoms of genetically confirmed sickle cell anaemia (404) and sickle beta thalassaemia (92) patients. Majority of the patients were from scheduled caste communities (47.9%) and Gond tribal community (13.8%). Splenomegaly was the most common clinical manifestation observed (71.4%). Overall, 63.5% patients had a history of blood transfusion. The most frequent signs and symptoms observed were Pallor, Icterus, Joint pain, Fever, and Fatigue. Majority of the patients revealed onset of disease prior to attaining the age of 3 years (sickle cell anaemia 44.3% and sickle beta thalassaemia 35.9%). Mean haemoglobin levels among SCA individuals were marginally higher than SBT patients. On the other hand, mean foetal haemoglobin levels among SBT individuals showed the reverse trend. Notably, the present study reports the first incidence of priapism recorded in Central India. The study revealed a high prevalence of SCD among scheduled caste, backward caste, and tribal communities. Dissemination of study findings, screening, pre-marriage counselling, and pre-natal diagnosis are fundamental to preventing or lowering of birth of sickle cell anaemia children in the affected populations.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058849449

Download citation: RISBibTeXText

PMID: 27077770

DOI: 10.1080/10245332.2016.1148893

Related references

The thalassaemia syndromes. VI. Two subtypes of sickle cell-beta thalassaemia disease: (a) normocytic type of sickle cell-beta thalassaemia disease (b) microcytic type of sickle cell-beta thalassaemia disease. Acta Haematologica 37(4): 181-188, 1967

Haematological change in sickle cell-haemoglobin C disease and in sickle cell-beta thalassaemia: a cohort study from birth. British Journal of Haematology 60(2): 279-292, 1985

Sickle-cell haemolglobin C disease and sickle-cell beta thalassaemia in white South Africans. South African Medical Journal 46(39): 1423-1426, 1972

Sickle-cell anaemia, sickle-cell thalassaemia, sickle-cell haemoglobin C disease, and asymptomatic haemoglobin C thalassaemia in one Ghanaian family. British Medical Journal 1(5644): 607-612, 1969

Comparison of sickle cell-beta0 thalassaemia with homozygous sickle cell disease. British Journal of Haematology 41(1): 83-93, 1979

Clinical and laboratory factors associated with the severity of proliferative sickle cell retinopathy in patients with sickle cell hemoglobin C (SC) and homozygous sickle cell (SS) disease. Medicine 90(6): 372-378, 2012

Simultaneous Radioactive Tracer Studies Of Erythropoiesis And Red-Cell Destruction In Sickle-Cell Disease And Sickle-Cell Haemoglobin/Thalassaemia. British Journal of Haematology 9: 487-498, 1963

Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia. Pediatric Hematology and Oncology 16(3): 221-232, 1999

Neutrophil chemotaxis in sickle cell anaemia, sickle cell beta zero thalassaemia, and after splenectomy. Journal of Clinical Pathology 40(6): 670-672, 1987

Sickle cell disease: a continuing clinical and research dilemma: Bone marrow transplantation for sickle cell disease Walters, M.C. et al. (1996) New Engl. J. Med. 335, 369376 Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial Ferster, A. et al. (1996) Blood 88, 19601961. Molecular Medicine Today 2(11): 450-451, 1996

Intriguing prevalence of benin type sickle cell gene on atypical haplotypes in sickle cell beta thalassemia but not in sickle cell anemia in sicily italy. Bank, A (Ed ) Annals Of The New York Academy Of Sciences, Vol 612 Sixth Cooley's Anemia Symposium; New York, New York, Usa, March 13-15, Xiii+590p New York Academy Of Sciences: New York, New York, Usa Illus Maps 502-503, 1990

Clinical hematologic and biosynthetic studies in sickle cell beta thalassemia a comparison with sickle cell anemia. American Journal of Hematology 1(1): 35-44, 1976

Comparison of sickle cell beta o thalassemia with homo zygous sickle cell disease. British Journal of Haematology 41(1): 83-94, 1979

Frequency distribution of sickle cell anemia, sickle cell trait and sickle/beta-thalassemia among anemic patients in Saudi Arabia. Journal of Natural Science, Biology, and Medicine 6(Suppl 1): S85-S88, 2015

Comparison in clinical course of sickle cell-beta- thalassemia and sickle cell anemia. Blood 86(10 Suppl. 1): 656A, 1995